Skip to main content

Table 1 Description of the population of patients with breast cancer diagnosed between 2007 and 2012 in three French administrative areas

From: Trends in molecular subtypes of breast cancer: description of incidence rates between 2007 and 2012 from three French registries

Variable

N = 12,040

%

Year

  

 2007

1976

16.4

 2008

1940

16.1

 2009

1910

15.9

 2010

2069

17.2

 2011

2063

17.1

 2012

2082

17.3

Age class

  

 < 40

547

4.5

 40–54

3447

28.6

 55–69

4377

36.4

 > = 70

3669

30.5

Biomarker

  

 ER+ (699 NA, 6%)

9492

78.8

 PR+ (707 NA, 6%)

8144

67.6

 HER2+ (1524 NA, 13%)

1239

10.3

Molecular subtype

  

 TN

1111

9.2

 HR+/HER2+

758

6.3

 HR+/HER2-

8041

66.8

 HR-/HER2+

447

3.7

 NA

1683

14.0

  1. ER: estrogen receptor, PR: progesterone receptor, HER2: human epidermal growth factor receptor, TN: triple negative; HR: hormonal receptor; NA: not available
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us